
    
      -  IL-2 will be given daily through an injection under the skin for a period of 8 weeks. To
           determine the highest safest dose of IL-2, the dose participants receive will increase
           as lower doses are determined to be safe. There will be three dose levels.

        -  Participants will be seen periodically while they are receiving IL-2. Physical exams and
           blood tests will be performed weekly for the first two weeks and then every other week
           until week 8.
    
  